Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v9-EN
Language English English
Date Updated 2019-03-02 2019-01-28
Drug Identification Number 02240518 02240518
Brand name MAXALT RPD MAXALT RPD
Common or Proper name rizatriptan benzoate wafers rizatriptan benzoate wafers
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 5MG 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 12wafers 12wafers
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-11-09 2018-11-09
Actual start date 2018-11-02 2018-11-02
Estimated end date 2019-03-01 2019-02-08
Actual end date 2019-03-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments